3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
7
Triple Negative Breast Neoplasms
5
Lung Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Neoplasm Metastasis
2
Breast Neoplasms
2
Uterine Cervical Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Rectal Neoplasms
1
Neoplasms
1
Metastatic Pancreatic Ductal Adenocarcinoma
1
Melanoma, Cutaneous Malignant
1
Head and Neck Neoplasms
1
GastroEsophageal Cancer
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Pancreatic Ductal
1
CLDN18.2 Positive
1
Anal Cancer Metastatic
1
Adenocarcinoma
1
Interventions
Oxaliplatin
8
Fluorouracil
8
pembrolizumab
7
Paclitaxel
6
Trastuzumab
5
Leucovorin
5
Capecitabine
5
Specimen Handling
4
Radiation
4
Cisplatin
4
Carboplatin
4
tislelizumab
3
patritumab deruxtecan
3
Taxes
3
Radiotherapy
3
Nivolumab
3
ulixertinib
2
trastuzumab deruxtecan
2
trastuzumab biosimilar HLX02
2
durvalumab
2
Surgical Procedures, Operative
2
Ramucirumab
2
Pemetrexed
2
PF-05280014
2
Ontruzant
2
Ogivri
2
Magnetic Resonance Spectroscopy
2
Irinotecan
2
Immunotherapy
2
Exercise
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Esophageal Neoplasms
×
Albumin-Bound Paclitaxel
×
30 days
×
Clear all
No trials found.